NewAmsterdam Pharma (NAMS) EBT Margin (2023 - 2026)
NewAmsterdam Pharma (NAMS) reported EBT Margin of 1593.45% for Q1 2026, down 26615.0% on a YoY basis from N/an in Q1 2025, and up 99.32% sequentially from 234134.38% in Q4 2025.
NewAmsterdam Pharma (NAMS) EBT Margin (2023 - 2026) Analysis & Trends
NewAmsterdam Pharma (NAMS) has 4 years of EBT Margin data on file, last reported at 1593.45% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 26615.0% year-over-year to 1593.45%; the trailing twelve-month figure through Mar 2026 stood at 942.76% (down 54530.0% YoY), and the FY2025 full-year result was 905.74%, down 37549.0% from the prior year.
- EBT Margin improved to 1593.45% in Q1 2026, from 234134.38% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 7233.75% in Q4 2023 to a low of 234134.38% in Q4 2025.
- A 4-year average of 20315.86% and a median of 1593.45% in 2026 frame the typical range for EBT Margin.
- Peak annual rise in EBT Margin reached 536556 bps in 2025, while the deepest fall reached 23341266 bps in 2025.
- Tracing NAMS's EBT Margin over 4 years: stood at 7233.75% in 2023, then plunged by 110 bps to 721.71% in 2024, then slumped by 32342 bps to 234134.38% in 2025, then jumped by 99 bps to 1593.45% in 2026.
- Business Quant data shows NAMS's EBT Margin at 1593.45% in Q1 2026, 234134.38% in Q4 2025, and 20691.09% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | NewAmsterdam Pharma | 3.72 Bn | 3.72 Bn | - | -1,593.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,593.45% |
| Dec 31, 2025 | -234,134.38% |
| Sep 30, 2025 | -20,691.09% |
| Jun 30, 2025 | -90.70% |
| Mar 31, 2025 | -1,327.30% |
| Dec 31, 2024 | -721.71% |
| Sep 30, 2024 | -57.19% |
| Jun 30, 2024 | -1,711.58% |
| Mar 31, 2024 | -6,692.86% |
| Dec 31, 2023 | 7,233.75% |
| Sep 30, 2023 | -1,602.62% |
| Jun 30, 2023 | -2,230.11% |
| Mar 31, 2023 | -486.94% |